Trimethoprim-sulfamethoxazole vs. colistin or ampicillin–sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study
ConclusionsTMP/SMX might be a valuable treatment option for TMP/SMX-susceptible CRAB infections. Given the very limited available treatment options, further studies assessing its effectiveness and safety are necessary.
Source: Journal of Global Antimicrobial Resistance - Category: Infectious Diseases Source Type: research
More News: Acinetobacter | Antimicrobial Resistance | Bactrim | Infectious Diseases | Intensive Care | Septic Shock | Study | Sulfamethoxazole | Trimethoprim